Fulton appoints new management team

Restructures Bristol-based business

Fulton was established in Bristol, UK in 1966 to manufacture vertical tubeless steam boilers. Today the company is part of Fulton Inc, a global manufacturer of steam, hot water and thermal fluid heat transfer systems with production facilities in the UK, US and China.

Following the retirement of the UK firm’s sales and marketing and technical directors, Fulton Inc has restructured the business and appointed Paul Richards as managing director and Carl Knight as UK and European sales and marketing manager.

Richards previously worked for Solatron, while Knight joins Fulton from Spirax Sarco.

Richards said: ‘The changes haven’t just stopped with management appointments. We have also restructured and changed the trading name from Fulton Boiler Works (GB) to Fulton, as we feel it better reflects the business and markets we now operate in.’

Once just a steam boiler manufacturer, Fulton now specialises in the design and manufacture of energy efficient products and ready-to-ship skid mounted and fully packaged boiler plant rooms, he added.

‘We put great emphasis on providing sales and application advice and a full commissioning and after sales service to a growing customer base in hospital and healthcare facilities, food and beverage processing, laundries and other applications.’

Fulton recently introduced of a VMP vertical tubeless boiler, ModSync boiler sequencing system and TDS energy recovery system.

You may also like

Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Manufacturing

Why integrated outsourcing wins in modern drug development

Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel workstreams and shared governance
Subscribe now